Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.

Bhatt, Deepak L; Briggs, Andrew H; Reed, Shelby D; Annemans, Lieven; Szarek, Michael; Bittner, Vera A; Diaz, Rafael; Goodman, Shaun G; Harrington, Robert A; Higuchi, Keiko; +11 more... Joulain, Florence; Jukema, J Wouter; Li, Qian H; Mahaffey, Kenneth W; Sanchez, Robert J; Roe, Matthew T; Lopes, Renato D; White, Harvey D; Zeiher, Andreas M; Schwartz, Gregory G; Gabriel Steg, Ph; ODYSSEY OUTCOMES Investigators; (2020) Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75 (18). pp. 2297-2308. ISSN 0735-1097 DOI: https://doi.org/10.1016/j.jacc.2020.03.029

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jacc.2020.03.029

Abstract

Share

Download

Filename: 1-s2.0-S0735109720346350-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar